Last update 05 Apr 2025

VF-001

Overview

Basic Info

Drug Type
Fusion protein
Synonyms
VF 001, VF-001-DP-HD, VF-001-DP-LD
+ [4]
Target
IGF-1R
Action
antagonists
Mechanism
IGF-1R antagonists(Insulin-like growth factor I receptor antagonists)
Therapeutic Areas
Cardiovascular DiseasesSkin and Musculoskeletal DiseasesOther Diseases+ [2]
Active Indication-
Inactive Indication
Diabetic foot ulcerPathologic ProcessesUlcer+ [1]
Originator Organization
Invert Graphite Ltd.Invert Graphite Ltd.
Active Organization-
Inactive Organization
Invert Graphite Ltd.Invert Graphite Ltd.
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with VF-001
NCT02973893
/ Unknown statusPhase 2
A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial Comparing Two Doses of VF001-DP to Placebo as an Adjunct to Standard Care in Patients With Chronic Venous Leg Ulcers
100 Clinical Results associated with VF-001
Login to view more data
100 Translational Medicine associated with VF-001
Login to view more data
100 Patents (Medical) associated with VF-001
Login to view more data
100 Deals associated with VF-001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pathologic ProcessesPhase 2
United States
Invert Graphite Ltd.Invert Graphite Ltd.
01 Nov 2016
UlcerPhase 2
United States
Invert Graphite Ltd.Invert Graphite Ltd.
01 Nov 2016
Varicose UlcerPhase 2
United States
Invert Graphite Ltd.Invert Graphite Ltd.
01 Nov 2016
Diabetic foot ulcerPreclinical
Australia
Invert Graphite Ltd.Invert Graphite Ltd.
28 Oct 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free